NasdaqGS:OPCHHealthcare
Assessing Option Care Health (OPCH) After Expanded Buybacks And 2026 Net Revenue Guidance
Option Care Health (OPCH) has drawn fresh attention after expanding its share repurchase authorization to US$1b, completing earlier buybacks, and issuing full year 2026 net revenue guidance of US$5.8b to US$6.0b.
See our latest analysis for Option Care Health.
Those announcements come after a strong run in the share price, with a 30 day share price return of 10.09% and a 90 day share price return of 26.51%, while the 1 year total shareholder return of 21.45% and 5 year total shareholder...